GLP-1s: Medicaids Expenditures As of 2023, 39 state Medicaid programs had unrestricted coverage for at least one GLP-1 drug to treat T2D
Long-Term Benefits With medical supervision, Semaglutide and Tirzepatide can provide safe, sustainable weight loss results that support better health and confidence
GLP-1 medications also reduce blood pressure, improve lipid profiles, decrease systemic inflammation, and show renal protective effects
non-supplemented baseline Before: 145 lbs, 28% body fat, active trainer, strong metabolic baseline Protocol: 300 kcal deficit, 1.8g protein/kg, 2g L-carnitine daily, 4 resistance + 3 cardio sessions weekly After: 135 lbs, 22% body fat (10 lbs loss, ~9 lbs fat + 1 lb muscle), visible abdominal and shoulder definition Result: L-carnitine + training allowed aggressive deficit while preserving strength
For most people, glutathione serum provides the best balance of safety, effectiveness, and long-term results
In relation to the IGF-1 LR3 pathway, this suggests that extended IGF-1 activity can effectively support muscle growth, tissue repair, and metabolic recovery, while maintaining a stable and regulated anabolic environment